A Clinical Study of KLH-2109 in Patients With Endometriosis

NCT07015268 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: KLH-2109
DRUG: Leuprorelin acetate

Sponsor

Kissei Pharmaceutical Co., Ltd.